Introduction
Mesenchymal stromal cells (MSC) are a key component of new cellular therapies, due to their multilineage differentiation potential and immunosuppressive capacities (1) . MSC can be derived from various adult and fetal tissues (2-4). Since no specific markers are available to exclusively isolate MSC from tissues, MSC are currently defined as plastic adherent cells that are capable of in vitro differentiation towards osteoblasts, chondrocytes and adipocytes (5). In addition, they express CD105, CD73, CD90 but do not express hematopoietic markers (5).
MSC have been successfully used in clinical trials to treat osteogenesis imperfecta (6) and graft-versus-host disease (7) and many other clinical applications are currently explored. For current clinical trials, tissue culture-based expansion of MSC is required to obtain a sufficient number of cells to allow successful transplantation. This cell culture step decreases the homing capacity of MSC (8). Correspondingly, in animal studies the majority of the culture-expanded MSC do not engraft and disappear within a few days after intravenous transplantation (9 ; 10). Therefore, it is suggested that the benefits of MSC transplantation are not only caused by locally engrafted cells but also by systemic effects of secreted factors.
It is often assumed that common mechanisms of cell migration also apply to MSC migration. Previous studies have identified chemotactic stimuli for MSC, such as stromal derived factor-1α (SDF-1α) (11 ; 12), platelet-derived growth factor (PDGF) (13) , hepatocyte growth factor (HGF) (14) and basic fibroblast growth factor (bFGF) (15) . These stimuli induce migration of MSC derived from various adult and fetal tissues (16) (17) (18) . In addition, MSC have the capacity to migrate across endothelial monolayers (19) , an important feature since MSC are administered intravenously in most clinical trials. However, we and others observed that only a small fraction of MSC shows efficient migration (9   ;   16 ; 20). Thus, it is important to elucidate why only a small proportion of all culture-expanded MSC is able to migrate and whether these migratory cells can be discriminated from non-migratory MSC in terms of function and phenotypic markers. In search for differences between migratory and non-migratory MSC, we reported that the molecular machinery involved in migration was functional in both groups. In addition, migratory and non-migratory cells could not be distinguished by cell surface markers such as integrins, adhesion molecules or chemokine and growth factor receptors (16) . Interestingly, we found that the cell cycle correlated with MSC migration. Similar to human hematopoietic stem cells (HSC), MSC in S-and G2/Mphase showed reduced migration compared to MSC in G1-phase (16 ; 21).
In the current study, we report on a search for novel factors that regulate MSC migration. We performed a micro-array-based gene expression analysis of migratory and nonmigratory FBMSC and identified two genes involved in FBMSC biology, which are significantly increased in migratory FBMSC compared to non-migratory cells; Nur77 and Nurr1. Overexpression of these nuclear receptors increased migration towards SDF-1α and enhanced cytokine production, while the immunosuppressive capacities of MSC were maintained.
Materials and Methods
Isolation and culture of MSC Fetal bone derived from four individual donors was obtained after informed consent from legally terminated second trimester pregnancies. The protocol for collecting fetal tissues for research purposes was approved by the medical ethical review board of the AMC (MEC: 03/038). To obtain fetal bone marrow MSC (FBMSC), fetal bones were flushed with IMDM (Lonza, Verviers, Belgium) containing 10% FCS (Bodinco, Alkmaar, The Netherlands), 50U/ mL penicillin and 50µg/mL streptomycin (Gibco, Paisley, UK). The remaining erythrocytes were lysed using NH 4 Cl for 10 minutes on ice. Subsequently, cells were rinsed in PBS. 
Flow cytometry
MSC were characterized for surface expression by flow cytometry. Cells were rinsed, trypsinized, washed and resuspended in PBS containing 0.2% BSA prior to incubation (20 minutes at RT) with the following monoclonal antibodies. Antibodies purchased from BD, San Jose CA: CD73 (clone AD2), CD90 (clone 5E10), CD45 (clone HI30). Antibodies from other companies: CD105 (clone SN6, Ancell, Bayport MN), CD34 (clone 581, IQ-products, Groningen, The Netherlands). As a negative control, cells were labeled with IgG1 isotype controls (monoclonal antibodies; Sanquin, BD). A minimum of 10.000 events was recorded, using a FACS LSR II flow cytometer (BD).
Differentiation experiments
To study the multilineage differentiation capacity, MSC were cultured under conditions that promote differentiation towards osteoblasts or adipocytes as previously described (22) . MSC were plated in a 24 well dish at a plating density of 2.5 x 10 4 cells/cm 2 in α-MEM (Gibco).
For osteogenic induction, α-MEM was supplemented with 10% FCS and penicillin (50 IU/ml), streptomycin (50 µg/ml) to which ascorbic acid (50 μg/mL, Sigma, St Louis, MI) and dexamethasone (10 -7 M, Sigma) were added. From day 7 onwards, β-glycero-phosphate (5 mM, Sigma) was added. Cultures were incubated in a humidified atmosphere of 5% CO 2 at 37˚C. Medium was replaced every 4 th and 7 th day of the week. For induction of adipogenesis, indomethacine (50 μM, MP Biomedicals, Solon, OH), IBMX (0.5 mM, Sigma) and insulin (1.6 µM, Sigma) were used. 
In vitro migration experiments
Migration experiments for collecting migratory and non-migratory MSC towards SDF-1α (600 ng/ml, Peprotech, Rocky Hill, NJ) were performed using 12 µm pore size Transwell plates (Corning Costar, Cambridge, MA). Optimal SDF-1α concentration for migration was determined previously (16) . The apical compartment was coated overnight with fibronectin (20 µg/mL, Sigma) in PBS. 100.000 cells were seeded into the apical compartment in 500 µL IMDM supplemented with 0.25% BSA (Sigma), and the stimulus was added to the basolateral compartment in 1.5 mL IMDM with 0.25% BSA. Cells were allowed to migrate for four hours.
For collection of migratory cells for RNA extraction and subsequent micro array analysis, 21 Transwell inserts were used. To obtain a pure migratory fraction, non-migratory MSC were removed from the apical side of the membrane using a cotton swap. After removing the non-migratory MSC, the inserts were carefully rinsed in PBS twice before trypsinizing the migratory MSC from the membrane. The cells were collected in en eppendorf tube and lysed in RLT buffer (Qiagen, Venlo, The Netherlands) supplemented with β-mercaptoethanol according to the manufacturers instructions. Non-migratory MSC were collected from three Transwell inserts. To collect a pure non-migratory FBMSC fraction, migratory MSC on the basolateral compartment of the Transwell membrane were reoved with a cotton swap. The filters were rinsed in PBS and non-migratory cells were collected by Trypsin detachment, collected and lysed as described.
To evaluate the percentage of migratory cells, 4 inserts (2 negative controls and 2 SDF-1α stimulated wells) were fixed in 3.7% formaldehyde and further stained with Hoechst 33258 (1:500 dilution, Invitrogen, Breda, The Netherlands). The Transwell filter membranes were mounted onto glass slides using Mowiol (Sigma). The total number of migrating cells per view field was qualified by counting nuclei using fluorescence microscopy. 23 .
Production of lentiviral particles
Lentiviral vectors for knock down and overexpression of Nur77 and Nurr1 have been described previously (23) . Briefly, 293T cells were cultured in DMEM (25 mM HEPES, Gibco) containing 10% FCS, penicillin (50 IU/mL), streptomycin (50 µg/mL), L-Glutamine (2 mM, Gibco) and transfected with pMDL-pRRE, pVSV-G and pRSV-REV and Nur77 or Nurr1 using the Calcium Phosphate method. Viral particles containing supernatant was harvested at day one and two after transfection. After ultracentrifugation, viral titers were determined as described by Sastry et al (24) . Briefly, serial dilutions of concentrated virus were used for transduction of 293T cells. 24 hours after transduction, total genomic DNA was isolated using a DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer's instructions. The number of inserted vector copies was determined by RQ-PCR, using the vector DNA for the standard curve. FW primer 5' CTGCAGCAGCAGAACAATTTG 3', RV primer 5'CCCCAGACTGTGAGTTGCAA 3'.
Transduction of MSC
100.000 MSC per well were plated in a fibronectin coated 6-well plate and allowed to adhere for 24 hours. For transduction, medium was replaced by IMDM+0.25% BSA containing viral particles (MOI 100 and 600 for overexpression and knock-down respectively). After over night exposure to the virus, the medium was replaced with M199c and the cells were cultured for another 24hrs. Transduction efficiency was evaluated by RQ-PCR.
Cell cycle analysis
Three days after transduction, MSC were plated at 10.000 cells/cm 2 and harvested for cell cycle analysis after 24 hours. Cells were trypsinized and fixed in 4% PFA at RT or in 70% EtOH on ice and subsequently permeabilized in 0.1 % Triton-X-100. MSC were then incubated with Ki67 (Clone MIB-1, Dako, Glostrup, Denmark) for 30 mins at 4°C in PBS containing 0.1% Triton-X-100. Finally, both overexpression and knock-down MSC were incubated for 15 mins at 37°C with labeling reagent containing Hoechst 33258 (1 µg/mL), RNase A (Sigma) and 0.1 % Triton-X-100. A minimum of 10.000 cells was analysed by flow cytometry as described above and further analyzed using Modfit LT 3.0 software (Verity Software House, Topsham, ME). Ratios were calculated for each cell cycle phase from the percentage of cells in a certain phase in migrating MSC divided by the percentage of cells in the same phase in non-migrating MSC.
Cytokine treatment of MSC and quantification of cytokines in culture supernatant
Three days after transduction, MSC were plated at a density of 15.000 cells/cm 2 in 24-well plates (Nunc) in M199c. After 24hrs, medium was refreshed and cells were stimulated with TNFα (1000 U/mL, Peprotech) or IFNγ (1000 U/mL, Peprotech) or left untreated. Conditioned medium and RNA samples were collected 6 and 24 hrs after stimulation. Expression levels of TGFβ1, HGF and IDO were determined by RQ-PCR as described above. Protein levels of IL-6, IL-8 and IL-10 were measured by ELISA using the PeliKine compact ELISA (Sanquin Reagents, Amsterdam, The Netherlands)
Immunofluorescent microscopy
Three days after transduction, 10.000 transduced or control MSC were seeded on fibronectincoated coverslips and were allowed to adhere for 24 hrs. The cells were fixed for 10 minutes on ice, then permeabilized using 0.2% Triton-X-100 (Sigma) and stained with anti-Nur77 (M210, Rabbit polyclonal, Santa Cruz Biotechnologies, Santa Cruz, CA) or anti-Nurr1 (N20, Rabbit polyclonal, Santa Cruz), followed by secondary goat-anti-rabbit Alexa 568 (20 μg/ml), Alexa 488 phalloidin and Dapi (All: Invitrogen Molecular Probes, Leiden, The Netherlands). Coverslips were then mounted using Mowiol (Sigma). Immunofluorescent staining was detected using a LSM 510 META confocal microscope (Zeiss, Jena, Germany) using a 40x oilobjective. Images were captured by ZEN 2007 confocal software (Zeiss).
Co-cultures MSC and PBMC
Immunosuppressive capacity of MSC was tested in a co-culture of MSC and peripheral blood mononuclear cells (PBMC). MSC from three individual donors were plated in graded doses in a 96-well flat-bottom plate in DMEM-Glutamax-I (Invitrogen) containing 50 U/mL penicillin, 50 U/mL streptomycin (Lonza, Verviers, Belgium) and 10% FBS (Greiner bio-one). Cells were allowed to adhere overnight. PBMC (1.0 x 10 5 /well) from one donor were added to the MSC and stimulated with human T-activator CD3/CD28 dynabeads (Invitrogen Dynal AS, Oslo, Norway) in a bead:cell ratio 1:5. After 5 days of co-culture, cells were pulsed with [ 
Statistical analysis
Statistical significance was determined by Man-Whitney U Test, using SPSS 15.0 (SPSS Inc, Chicago, IL), except for cell cycle data which were analyzed by One-Sample KolmogorovSmirnov Test. Results were considered significant when p≤0.05.
Results

Characterisation of FBMSC
The FBMSC isolated from all four donors had a spindle shaped morphology and differentiated towards osteoblasts and adipocytes upon induction of differentiation (Supplementary figure 1) . In addition, these FBMSC expressed CD73, CD90 and CD105, and did not express the hematopoietic markers CD34, CD45 (Supplementary table 2) , CD11b, CD14, CD19 and HLA-DR (data not shown). Thus, based on these currently accepted criteria, these cells were designated as MSC.
Gene expression profiling of migratory MSC
Transwell migration experiments were performed to separate migratory from non-migratory FBMSC fractions prior to transcriptome analysis using Affymetrix Human Exon 1.0 ST arrays. Whereas 5.4±0.6 % (n=4) of the cells showed spontaneous migration, SDF-1α stimulated migration of 11.2±0.2 % (n=4) of the cells (Supplementary figure 2) . These data are in agreement with our previous results (16) .RNA was isolated from FBMSC that did or did not show a chemotactic response towards SDF-1α and this RNA was hybridized to Affymetrix Human Exon 1.0 ST array. We performed an analysis of variance (ANOVA) on the log2 probe intensities (representing the gene expression intensities) of 6 samples from three FBMSC donors and did a post-hoc analysis to compare migratory and non-migratory samples. Only twelve genes were differentially expressed with statistical significance (p<0.05) with a minimum fold change of 1.6 between migratory and non-migratory MSC ( Table 1 ). The nuclear orphan receptors NR4A1 (Nur77/TR3) and NR4A2 (Nurr1/NOT), Table 1 Differentially hereafter referred to as Nur77 and Nurr1 respectively, were the only two genes that were increased by more than two fold in migratory FBMSC as compared to non-migratory FBMSC. The array data were successfully confirmed by RQ-PCR on the samples used for the micro array as well as on samples obtained from independent migration experiments (Figure 1 ).
Nur77 and Nurr1 are members of the NR4A subfamily of nuclear orphan receptors that comprises three members. They are believed to function as ligand-independent early response genes that are involved in proliferation, apoptosis and inflammation (Reviewed in (25 ; 26). The third member of the NR4A family, NOR-1 (NR4A3) was not differentially expressed between migratory and non-migratory FBMSC (Figure 1 ).
SDF-1α and PDGF-BB induce Nur77 and Nurr1 mRNA expression in FBMSC
Gene expression of all three NR4A family members is enhanced in response to various growth factors, chemokines and cytokines in, amongst others, vascular smooth muscle cells (27) , endothelial cells (28) and macrophages (23 ; 29) . To study whether exposure to SDF-1α increases Nur77 and Nurr1 expression in MSC, FBMSC were exposed to 600 ng/ml SDF-1α for different time-periods. A maximum increase in Nur77 (4.4 fold) and Nurr1 (4.9 fold) expression was observed already after two hours (Figure 2A-B) . This effect was transient, as expression of both Nur77 and Nurr1 declined to control levels after 8 hrs. To test whether this induction was specific for SDF-1α, FBMSC were also exposed to platelet-derived growth factor-BB (PDGF-BB), which is a growth factor that is a potent chemoattractant for MSC (13 ; 30). Similar to SDF-1α, exposure to PDGF-BB induced mRNA expression of Nur77 with a maximum around 2 hrs ( Figure 2C ), while Nurr1 was induced to a lesser extent ( Figure 2D ).
Micro array confirmation by RQ-PCR Figure 1
The increased expression of Nur77 and Nurr1 in migratory FBMSC compared to non-migratory MSC was confirmed by RQ-PCR for Nur77 (left) and Nurr1 (middle). Bars depict the fold increase (mean ± SD, n=3) of migratory FBMSC normalized to non-migratory FBMSC. The third family member Nor1 (right) was confirmed not differentially expressed. * p≤ 0.05
Overexpression of Nur77 and Nurr1 enhances MSC migration
Subsequently, FBMSC were transduced with lentivirus to induce overexpression of Nur77 and Nurr1. Cells were analysed 72 hrs after viral transduction. In Nur77-or Nurr1-transduced FBMSC, immunofluorescent staining was observed predominantly in the nucleus as expected (Supplementary figure 3A) . Overexpression was also validated by RQ-PCR (Supplementary figure 3B) . As Nur77 and Nurr1 expression under basal conditions is very low (7±0.9 Ct lower than ABL), transduction results in very high expression of these genes. Lentiviral transduction did not influence the classical MSC phenotype (Supplementary table  2 ). Nur77 and Nurr1 expression was increased upon induction of differentiation towards osteoblasts or adipocytes (Nur77 16 fold, Nurr1 3 fold) in wild type and mock-transduced MSC. This elevated expression persisted during the complete differentiation period (data not shown). In agreement with these findings, the differentiation capacity of FBMSC towards osteoblasts or adipocyte upon induction of differentiation was not affected (Supplementary figure 1) . Importantly, overexpression of Nur77 or Nurr1 did not induce spontaneous Because expression levels of Nur77 and Nurr1 were increased in migratory MSC, we tested for a causal relationship by determining whether overexpression of Nur77 or Nurr1 in FBMSC results in enhanced migration towards SDF-1α. Importantly, overexpression of Nur77 or Nurr1 did not influence expression of CXCR4, the receptor for SDF-1α. Three days after transduction, Nur77, Nurr1 or mock-transduced FBMSC were allowed to migrate towards SDF-1α for four hours in a Transwell-based chemotaxis assay. As depicted in Figure  3 , expression of Nur77 and Nurr1 significantly increased chemotaxis as compared to mocktransduced FBMSC (Nur77 mean 297% ± 186 relative to mock, p≤ 0.014, n=4; Nurr1 mean 227% ± 79, p≤ 0.014, n=4).
Nur77 and Nurr1 are involved in FBMSC cell cycle regulation
We previously showed that migration of MSC depends on cell cycle status. Cells in Sand G2/M-phase have a reduced migratory capacity (16) . Nur77 and Nurr1 are known to be involved in cell cycle regulation of endothelial cells (28 ; 34) and smooth muscle cells (35) . We therefore studied the role of Nur77 and Nurr1 in cell cycle regulation of FBMSC. Three days after lentiviral transduction, mock-, Nur77-or Nurr1-transduced FBMSC were seeded at identical cell densities in fibronectin-coated 6-well plates. The next day, cells
Overexpression of Nur77 and Nurr1 increases specific FBMSC migration Figure 3
Mock-, Nur77-and Nurr1-transduced FBMSC were allowed to migrate for 4hrs towards 600 ng/ml SDF-1α or control medium. The percentage of migratory cells was evaluated by fluorescence microscopy. The bars represent the percentage (mean ± SD) specific migration (% SDF-induced migration-% spontaneous migration) relative to mocktransduced FBMSC. SDF-1α, stromal cell-derived factor 1α. * p≤ 0.05.
were harvested for cell cycle analysis by flow cytometry. Overexpression of Nur77 or Nurr1 significantly reduced the proportion of cells in S-phase from 19.7% to 8.9% and 7.3% respectively (a reduction of 38±10% (p<0.04, n=4) and 33±17% (p<0.039, n=4)) ( Figure  4A ). The percentage of cells in G0/G1 was concomitantly increased (Figure 4A ). The altered cell cycle distribution in Nur77 and Nurr1 transduced cells suggest decreased proliferation in these groups. Although cell numbers were increased in all treatment groups three days after transduction, fewer cells were harvestd from Nur77 (fold increase in three days 1.5 ± 0.6, n=4) and Nurr1 (1.4 ± 0.6, n=4) transduced groups compared to Mock (1.8 ± 0.7, n=4) or non-transduced cells (1.9 ± 0.8, n=4). Because overexpression of Nur77 or Nurr1 did not increase apoptosis (data not shown), the decreased cell numbers in Nur77 and Nurr1 transduced cells are most likely due to decreased proliferation. ShRNA-based reduction of Nur77 and Nurr1 expression was achieved by lentiviral transduction. Transduction efficiency determined by flow cytometry was 90-100% (data not shown) and this reduced expression of Nurr77 with 2.2±0.3 fold and Nurr1 11±8 fold (Supplementary figure 3C) . Unfortunately, we were not able with the currently available antibodies to detect endogenous Nur77/Nurr1 protein expression in these cells. The specificity of our shRNA sequences has, however, been tested extensively both at mRNA and at protein level (36) . In agreement with the decreased percentage of cells in S-phase observed in cells that overexpress Nur77 and Nurr1, loss of their expression by shRNA transduction induced an increase in the fraction of cells in S-phase from 16% in shCTRL-transduced cells to 24% (shNur77) or 25% (shNurr1), an increase of 37±11% p<0.036, n=3 and 45±12%, p<0.03, n=3) ( Figure 4B ). Correspondingly, the percentage of cells in G2/M-phase was also increased (percentage increase G2/M 76±3% p<0.021, n=3 (Nur77); 72±3%, p<0.021, n=3 (Nurr1)) and the fraction of cells in G0/G1-phased was decreased ( Figure 4B ).
These data show that Nur77 and Nurr1 are involved in cell cycle regulation in MSC. Moreover, our findings that high expression levels lead to decreased proliferation and increased chemotaxis are in full agreement with our earlier results (16) showing that decreased proliferation correlates positively with increased migration (16).
Nur77 and Nurr1 increase cytokine and growth factor production MSC secrete a wide variety of cytokines, chemokines and growth factors (37) that contribute to MSC-mediated immune suppression (38 ; 39). Interleukin (IL)-6, IL-8, IL-10, hepatocyte growth factor (HGF), transforming growth factor (TGF)β1 and indoleamine-2,3-dioxygenase (IDO) secreted by MSC are key factors in suppressing T-cell proliferation and monocyte differentiation (1 ; 40). Overexpression of NR4A family members in macrophages resulted in an anti-inflammatory secretory profile (23) . Thus, we studied whether Nur77 and Nurr1 affect cytokine and growth factor release in FBMSC under basal and tumor necrosis factor (TNF)-α-or interferon (IFN)γ-stimulated conditions.
Expression of Nur77 and Nurr1 leads to significantly increased secretion of IL-6 and IL-8 protein and an increase in mRNA for HGF in otherwise unstimulated cells ( Figure 5A ). IL-10 protein was not detected (data not shown). IL-6 and IL-8 protein levels were enhanced by TNF-α, whereas HGF expression was increased by IFNγ. Under all conditions, Nur77 and Nurr1 expression resulted in a statistically significant, further increase in IL-6, IL-8 release and HGF mRNA levels ( Figure 5B ). TGFβ1 mRNA expression was not influenced by overexpression of Nur77 or Nurr1, nor by TNF-α or IFNγ stimulation (Figure 5A-B) . Expression of IDO, important for inhibition of T-cell proliferation (41), was strongly induced by IFNγ exposure as described previously (42) . IFN-γ induced IDO expression was not changed in case of Nur77 or Nurr1 gain of function (Figure 5A-B) . In contrast to overexpression, reduction of Nur77 or Nurr1 expression did not consistently reduce the production of IL-6 and IL-8 or expression of HGF, TGFβ1 or IDO (data not shown). This may be expected as expression of Nur77 and Nurr1 is low under homeostatic conditions and expression is rapidly induced upon stimulation of a wide range of cytokines. These data show that upon increase of Nur77 or Nurr1 expression, production of IL-6 and IL-8 and expression of HGF in FBMSC is enhanced, however expression of Nur77 or Nurr1 is not required for production of these cytokines. 
Increased cytokine production in Nur77 and Nurr1 transduced FBMSC does not influence T-cell proliferation Figure 5
Overexpression of Nur77 or Nurr1 does not affect immune suppression by FBMSC
In a final series of experiments, we tested whether increased expression of Nur77 and Nurr1, which results in increased migration and cytokine production by MSC (Figure 3 and Figure  5 ), alters the capacity of FBMSC to inhibit T-cell proliferation. FBMSC from three individual donors were co-cultured with CD3/CD28 bead-activated peripheral blood mononuclear cells (PBMC) from one donor. Similar to mock-transduced FBMSC, Nur77-and Nurr1-transduced cells were able to inhibit T-cell proliferation as determined by 3H-thymidine incorporation ( Figure 5C-D) . Only at a very high ratio (1:3) of PBMC versus FBMSC, Nurr1-transduced FBMSC showed a significantly decreased capacity to inhibit T-cell proliferation (n=3, p<0.030, Figure 5D ) compared to the mock-transduced cells.
Thus the altered cytokine profile in FBMSC caused by overexpression of Nur77 or Nurr1 does not impair MSC-mediated suppression of T-cell proliferation.
Discussion
MSC are interesting candidates for cellular therapy due to their multilineage differentiation potential and immunosuppressive capacities. Culture expansion of MSC is required to obtain the required quantity for clinical application; however culture-expansion impairs the homing capacity of MSC to the bone marrow (8). Thus, insight into the process of MSC migration and targeting is imperative for improving cellular therapies. In the present study, we identified the nuclear receptors Nur77 and Nurr1 as two genes regulating FBMSC migration and cytokine production.
In our transcriptome analysis of migratory and non-migratory MSC, only twelve genes were differentially expressed. This set did not include cell surface markers that enable selection for a migratory subset, nor did it include previously reported genes associated with enhanced MSC migration such as CD49f and PODXL (43). The transcription factors Nur77 and Nurr1 gave the most specific expression in migratory cells. Nur77 and Nurr1 are members of the NR4A subfamily of nuclear orphan receptors that function as ligand-independent early response genes involved in proliferation, apoptosis and inflammation. NR4A members are thought to act as constitutively active transcription factors that bind the promoter of target genes on consensus NBRE sites. Only a few direct target genes have been identified to date (Reviewed in (25 26)). Expression of Nur77 has not been described in MSC before, whereas increased expression of Nurr1 was observed in adult BMSC exposed to SDF-1α (44) or CXCL7 (45) . In these two studies, no functional experiments on Nurr1 were performed. The findings in adult BMSC are in good agreement with our data obtained with FBMSC, in which exposure to SDF-1α or PDGF-BB alone rapidly induced an increase in expression of Nur77 and Nurr1.
Since we found Nur77 and Nurr1 to be upregulated in migratory MSC, a lentiviral expression approach was used to study the contribution of these proteins to FBMSC migration. Indeed, expression of Nur77 or Nurr1 in FBMSC significantly increased migration compared to mock-transduced cells. These observations correspond well to impaired migration observed in dopaminergic neurons from Nurr1-null mice (46) and the reduced migration observed after reduction of Nurr1 expression in endothelial cells (28) and tumor cell lines (47) . Furthermore, Nur77 was described to be amongst the 17 genes associated with primary solid tumor metastasis (48) . No previous study has reported that overexpression of Nur77 can enhance cell migration.
Although the mechanism by which Nur77 and Nurr1 enhance cell migration is unknown, these proteins could favor MSC migration by modulating the cell cycle. In endothelial cells, proliferation is decreased either when Nur77 is highly expressed (34) or Nurr1 expression is low (28) . In vascular smooth muscle cells, Nur77 decreases proliferation (35) . Recently, Sirin et al demonstrated that Nurr1 overexpression drives HSC to quiescence (49) . Thus involvement of Nur77 and Nurr1 in cell cycle regulation is well established, promoting or inhibitory effects may be cell type dependent.
Our data show that in FBMSC, Nur77 and Nurr1 decrease the proportion of cells in S-phase, whereas a loss of expression promotes cell cycle progression. The observations that Nur77 and Nurr1 promote MSC migration and decrease proliferation are in agreement with our previous finding that MSC in S-and G2/M-phase of the cell cycle are less prone to migrate (16) .
Several studies revealed that the NR4A can inhibit the NFkB pathway and as such regulate cytokine synthesis (23 ; 50
; 51). The interaction between NFkB and NR4A may be a common mechanism, as this was reported in macrophages (23 ; 29), synoviocytes (50), microglia and asterocytes (51) .
As Nur77 and Nurr1 enhance FBMSC migration and regulate inflammatory cytokine production in macrophages (23 ; 52), it was important to test if Nur77 and Nurr1 expression in FBMSC would promote the immune modulatory capacities of these cells. Therefore, we studied the effect of Nur77 and Nurr1 on cytokine and growth factor production in FBMSC under basal and inflammatory conditions. In both conditions, Nur77 and Nurr1 increased IL-6 and IL-8 production and HGF mRNA expression, showing that also in FBMSC, Nur77 and Nurr1 promote the production of certain cytokines. A strong increase of IL-8 production by Nurr1 with a synergistic effect of TNF-α was also found in synoviocytes (50) .
Based on the increased levels of HGF, IL-6 and IL-8 it cannot be predicted which effect Nur77 and Nurr1 would exert on MSC-mediated immune suppression. Increased production of HGF may result in stronger immune suppression by FBMSC overexpressing Nur77 or Nurr1 (38) . Elevated levels of IL-6 are associated with both pro-and anti-inflammatory processes such as neutrophil and leukocyte infiltration (53) or inhibition of monocyte maturation and differentiation by MSC (54), while IL-8 enhances inflammation by inducing neutrophil chemotaxis (55) . Our co-culture experiments of transduced MSC with PBMC showed that Nur77 or Nurr1 transduced FBMSC were able to efficiently inhibit T-cell proliferation similar to control cells at low ratios of MSC vs PBMC. Only at a non-physiological ratio, inhibition of T-cell proliferation by Nurr1 transduced FMBSC was significantly reduced.
In summary, we have identified two genes, Nur77 and Nurr1, that promote migration of FBMSC. In addition, Nur77 and Nurr1 expression increases MSC cytokine production, while these MSC retained the capacity to inhibit T-cell proliferation. Because expression of Nur77 and Nurr1 can be induced by various growth factors and cytokines, studies on cytokine pretreatment for optimal transient upregulation of Nur77 and Nurr1 in MSC will contribute to enhancing MSC migration in a pre-clinical and clinical setting. In conclusion, modulation of Nur77 and Nurr1 expression in MSC therefore offers perspectives to endow migratory MSC with the capacity to specifically regulate the local immune response.
SDF-1α-induced chemotaxis in FBMSC Supplementary Figure 2
To confirm SDF-1α-induced chemotaxis in the experiments from which cells were collected for gene expression profiling, four Transwell wells were evaluated to quantify the percentage of SDF-1α induced migration. Wild type FBMSC were allowed to migrate for 4 hours towards SDF-1α (600 ng/ml). Medium alone served as a negative control. The number of migratory cells was counted by fluorescence microscopy. Bars represent the percentage (mean ± SD) of migrated MSC related to the cell number loaded in the upper compartment (n=4). *, p≤0.05.
